(Q39429336)

11 September 2017

title

Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity (English)

1 reference

11 September 2017

0 references

Mira Rosenblat

1

1 reference

11 September 2017

Nina Volkova

series ordinal

2

1 reference

11 September 2017

Michael Aviram

series ordinal

3

1 reference

11 September 2017

publication date

1 November 2011

1 reference

11 September 2017

1 reference

11 September 2017

volume

37

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

462-467

1 reference

Macrophages in the pathogenesis of atherosclerosis

11 September 2017

cites work

1 reference

The three-gene paraoxonase family: physiologic roles, actions and regulation

21 January 2018

1 reference

PON-dering differences in HDL function in coronary artery disease

21 January 2018

1 reference

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

21 January 2018

1 reference

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

21 January 2018

1 reference

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

21 January 2018

1 reference

Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice

21 January 2018

1 reference

Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice

21 January 2018

1 reference

Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation

21 January 2018

1 reference

Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine

21 January 2018

1 reference

Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization

21 January 2018

1 reference

High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.

21 January 2018

1 reference

Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages

21 January 2018

1 reference

Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.

21 January 2018

1 reference

The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function

21 January 2018

1 reference

The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux

21 January 2018

1 reference

Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress

21 January 2018

1 reference

Macrophage paraoxonase 1 (PON1) binding sites

21 January 2018

1 reference

HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress

21 January 2018

1 reference

Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation

21 January 2018

1 reference

The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BIOF.188

1 reference

11 September 2017

1 reference